134 related articles for article (PubMed ID: 6609175)
1. Hereditary hemorrhagic telangiectasia versus CREST syndrome: can serology aid diagnosis?
Fritzler MJ; Arlette JP; Behm AR; Kinsella TD
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 1):192-6. PubMed ID: 6609175
[TBL] [Abstract][Full Text] [Related]
2. [Hemorrhagic hereditary telangiectasia and CREST syndrome].
Zapatero Gaviria A; Fraile Rodríguez G; Harto Castaño A; Zea Mendoza A
Med Clin (Barc); 1985 Nov; 85(15):642-3. PubMed ID: 4079553
[No Abstract] [Full Text] [Related]
3. The diagnostic quandary of hereditary haemorrhagic telangiectasia vs. CREST syndrome.
Lee JB; Ben-Aviv D; Covello SP
Br J Dermatol; 2001 Oct; 145(4):646-9. PubMed ID: 11703295
[TBL] [Abstract][Full Text] [Related]
4. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
5. Prominent telangiectasia associated with marked bleeding in CREST syndrome.
Ueda M; Abe Y; Fujiwara H; Fujimoto W; Arakawa K; Arata J; Yoshioka T; Tomoda J; Katayama H
J Dermatol; 1993 Mar; 20(3):180-4. PubMed ID: 8478499
[TBL] [Abstract][Full Text] [Related]
6. [Differential diagnosis of Osler's telangiectasia and the CREST syndrome: significance of centromere antibodies].
Stolz W; Ring J; Meurer M
Hautarzt; 1988 Jun; 39(6):371-4. PubMed ID: 3403273
[TBL] [Abstract][Full Text] [Related]
7. Anticentromere antibodies--clinical correlates.
Wade JP; Sack B; Schur PH
J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
[TBL] [Abstract][Full Text] [Related]
8. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
9. Hereditary hemorrhagic telangiectasia with florid osseous dysplasia. Report of a case with differential diagnostic considerations.
Rhodus NL; Kuba R
Oral Surg Oral Med Oral Pathol; 1993 Jan; 75(1):48-53. PubMed ID: 8419874
[TBL] [Abstract][Full Text] [Related]
10. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
11. [Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): clinical manifestations and multidisciplinary management].
Frigerio C; Aebischer N; Baud D; Bonafe L; Fellmanne F; Ikonomidis C; Mazzolai L; Michel P; Nichita C; Qanadli SD; Lazor R
Rev Med Suisse; 2016 May; 12(517):896-901. PubMed ID: 27323484
[TBL] [Abstract][Full Text] [Related]
12. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
[TBL] [Abstract][Full Text] [Related]
13. Systematic screening in hereditary hemorrhagic telangiectasia: a review.
Kroon S; Snijder RJ; Faughnan ME; Mager HJ
Curr Opin Pulm Med; 2018 May; 24(3):260-268. PubMed ID: 29470256
[TBL] [Abstract][Full Text] [Related]
14. Hereditary Hemorrhagic Telangiectasia Management.
Peterson J
Radiol Technol; 2017 Jan; 88(3):277-294. PubMed ID: 28298578
[TBL] [Abstract][Full Text] [Related]
15. [Rendu-Osler-Weber disease (hereditary hemorrhagic telangiectasia). Report of 30 cases].
Morales Angulo C; Megía López R; del Valle Zapico A; Mazón Gutiérrez A; García Mantilla J; Rama Quintela JJ
Acta Otorrinolaringol Esp; 1997; 48(8):625-9. PubMed ID: 9528135
[TBL] [Abstract][Full Text] [Related]
16. [Sclerodermiform, plaque-like essential telangiectasias].
Hoede N; Korting GW
Hautarzt; 1978 Jan; 29(1):44-5. PubMed ID: 627484
[No Abstract] [Full Text] [Related]
17. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
18. [Anti-centromere antibody (ACA) and its significance for the diagnosis of CREST syndrome].
Chen SE; Gu YY; Xu YH
Zhonghua Nei Ke Za Zhi; 1986 Dec; 25(12):736-8, 776. PubMed ID: 3494576
[No Abstract] [Full Text] [Related]
19. Genetic counseling and testing for hereditary hemorrhagic telangiectasia.
Lam S; Guthrie KS; Latif MA; Weiss CR
Clin Genet; 2022 Mar; 101(3):275-284. PubMed ID: 34415050
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial hypertension as the first manifestation in a patient with hereditary hemorrhagic telangiectasia.
Ishiwata T; Terada J; Tanabe N; Abe M; Sugiura T; Tsushima K; Tada Y; Sakao S; Kasahara Y; Nakanishi N; Morisaki H; Tatsumi K
Intern Med; 2014; 53(20):2359-63. PubMed ID: 25318803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
